Literature DB >> 19211814

Leptin: a pivotal regulator of human energy homeostasis.

I Sadaf Farooqi1, Stephen O'Rahilly.   

Abstract

The identification of the hormone leptin by Friedman et al (1) in 1994 has proved to be a seminal observation in biomedical science. The discovery that a circulating protein secreted almost exclusively by adipocytes could regulate body weight through its effects on food intake and energy expenditure represented a remarkable breakthrough in our understanding of the molecular components of the systems involved in energy homeostasis. In this article, we describe how the identification of humans with mutations in the gene encoding leptin and the characterization of the associated clinical phenotype of congenital leptin deficiency, which includes hyperphagia, severe obesity, hypogonadism, and impaired immunity, has provided insights into the role of leptin-responsive pathways in the regulation of eating behavior, intermediary metabolism, and the onset of puberty. We and others have also been able to demonstrate that leptin signaling plays a critical role in the regulation of reproductive and immune function in humans, which places leptin at the center of the complex networks that coordinate changes in nutritional state with many diverse aspects of mammalian biology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211814     DOI: 10.3945/ajcn.2008.26788C

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  95 in total

1.  Getting biological about the genetics of diabetes.

Authors:  Christopher B Newgard; Alan D Attie
Journal:  Nat Med       Date:  2010-04       Impact factor: 53.440

Review 2.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

Review 3.  From observation to experimentation: leptin action in the mediobasal hypothalamus.

Authors:  Kevin W Williams; Michael M Scott; Joel K Elmquist
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

4.  A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.

Authors:  Wai W Cheung; Wei Ding; Sujana S Gunta; Yong Gu; Rinat Tabakman; Leah N Klapper; Arieh Gertler; Robert H Mak
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

5.  Aging effects on exercise-induced alternations in plasma acylated ghrelin and leptin in male rats.

Authors:  Ya-Wen Hsu; Yi-Ju Pan; Yu-Min Cho; Tsan-Hon Liou; Pesus Chou; Paulus S Wang
Journal:  Eur J Appl Physiol       Date:  2010-11-03       Impact factor: 3.078

Review 6.  Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.

Authors:  Bettina Mittendorfer
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-11       Impact factor: 4.294

Review 7.  The utility of animal models to evaluate novel anti-obesity agents.

Authors:  Steven P Vickers; Helen C Jackson; Sharon C Cheetham
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 8.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

Review 9.  Leptin in humans: lessons from translational research.

Authors:  Susann Blüher; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

10.  Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered 'wanting' for reward: entire core and medial shell mapped as substrates for PIT enhancement.

Authors:  Susana Peciña; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2013-03-17       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.